Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlortetracycline hydrochloride |
Is a |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline bisulfate |
Is a |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline calcium complex |
Is a |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline adverse reaction |
Causative agent (attribute) |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Allergy to chlortetracycline (finding) |
Causative agent (attribute) |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Product containing chlortetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Product containing chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
2 |
Product containing chlortetracycline in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Product containing chlortetracycline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Allergy to chlortetracycline (finding) |
Causative agent (attribute) |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Chlortetracycline bisulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline calcium complex |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
|
Chlortetracycline-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Chlortetracycline-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Chlortetracycline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Product containing only chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
2 |
Chlortetracycline only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Chlortetracycline only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortetracycline (substance) |
Inferred relationship |
Some |
1 |